Potential therapy derived from a banana protein works against SARS-CoV-2
A paper in Cell Reports Medicine details the efficacy of H84T-BanLec against all known human-infecting coronaviruses, including MERS, the original SARS, and SAR
Stay updated with breaking news from Peter Hinterdorfer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A paper in Cell Reports Medicine details the efficacy of H84T-BanLec against all known human-infecting coronaviruses, including MERS, the original SARS, and SAR
Article content “Lectins are proteins that can bind the sugar molecule structure on lipids or proteins such as the spike protein. Our idea is to harness this property to develop a drug to combat COVID-19 disease.” What you see in the video, he said, is the single spike (the large bright object) and lectins (smaller fast-moving objects). It was shot at 303 milliseconds per frame over an area of the virus measuring 100 X 100 nm² (nanometres are one-billionth of a metre), using something called atomic force microscopy at the University of Linz, Austria. “This is what it looks like in real...
Date Time Potential ‘Achilles’ heel’ of SARS-CoV-2 virus captured on video Proteins known as lectins can bind to the spike protein on the SARS-CoV-2 virus and prevent it from accessing human cells, an international team of researchers led by the University of British Columbia’s Dr. Josef Penninger has demonstrated. They have captured the action on the pathogen’s spike protein via video. “Lectins are proteins that can bind the sugar molecule structure on lipids or proteins such as the spike protein,” explains Dr. Penninger, director of the Life Sciences Institute in Vancouver. â€...